{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:02:15Z","timestamp":1790193735043,"version":"4.1.0"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Schizophr"],"DOI":"10.1038\/s41537-025-00664-4","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T11:11:14Z","timestamp":1756120274000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association between antidiabetic drug targets and psychiatric disorders"],"prefix":"10.1038","volume":"11","author":[{"given":"Rui","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guorui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunqing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhewei","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyanan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8096-3568","authenticated-orcid":false,"given":"Yaoyao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yundan","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyang","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1201-8465","authenticated-orcid":false,"given":"Weihua","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,25]]},"reference":[{"key":"664_CR1","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S2215-0366(21)00395-3","volume":"9","author":"GBD 2019 Mental Disorders Collaborators","year":"2022","unstructured":"GBD 2019 Mental Disorders Collaborators Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Psychiatry 9, 137\u2013150 (2022).","journal-title":"Lancet Psychiatry"},{"key":"664_CR2","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","volume":"391","author":"A Cipriani","year":"2018","unstructured":"Cipriani, A. et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet 391, 1357\u20131366 (2018).","journal-title":"Lancet"},{"key":"664_CR3","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1038\/mp.2012.47","volume":"17","author":"S Miyamoto","year":"2012","unstructured":"Miyamoto, S., Miyake, N., Jarskog, L. F., Fleischhacker, W. W. & Lieberman, J. A. Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents. Mol. Psychiatry 17, 1206\u20131227 (2012).","journal-title":"Mol. Psychiatry"},{"key":"664_CR4","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.2337\/diacare.24.6.1069","volume":"24","author":"RJ Anderson","year":"2001","unstructured":"Anderson, R. J., Freedland, K. E., Clouse, R. E. & Lustman, P. J. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diab. Care 24, 1069\u20131078 (2001).","journal-title":"Diab. Care"},{"key":"664_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2022.101319","volume":"48","author":"M-H Chen","year":"2022","unstructured":"Chen, M.-H. et al. Type 1 diabetes mellitus and risks of major psychiatric disorders: a nationwide population-based cohort study. Diab. Metab. 48, 101319 (2022).","journal-title":"Diab. Metab."},{"key":"664_CR6","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1093\/ijnp\/pyaa097","volume":"24","author":"Y Mizuki","year":"2021","unstructured":"Mizuki, Y. et al. Mechanisms underlying the comorbidity of schizophrenia and type 2 diabetes mellitus. Int. J. Neuropsychopharmacol. 24, 367\u2013382 (2021).","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"664_CR7","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13893","volume":"53","author":"H Tao","year":"2023","unstructured":"Tao, H. et al. Psychiatric disorders and Type 2 diabetes mellitus: a bidirectional Mendelian randomization. Eur. J. Clin. Invest. 53, e13893 (2023).","journal-title":"Eur. J. Clin. Invest."},{"key":"664_CR8","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s11920-010-0165-z","volume":"13","author":"A Campayo","year":"2011","unstructured":"Campayo, A., G\u00f3mez-Biel, C. H. & Lobo, A. Diabetes and depression. Curr. Psychiatry Rep. 13, 26\u201330 (2011).","journal-title":"Curr. Psychiatry Rep."},{"key":"664_CR9","doi-asserted-by":"publisher","first-page":"4880","DOI":"10.1017\/S003329172200174X","volume":"53","author":"L Townsend","year":"2023","unstructured":"Townsend, L. et al. Brain glucose metabolism in schizophrenia: a systematic review and meta-analysis of 18FDG-PET studies in schizophrenia. Psychol. Med. 53, 4880\u20134897 (2023).","journal-title":"Psychol. Med."},{"key":"664_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.2117","volume":"11","author":"C Wu","year":"2021","unstructured":"Wu, C. et al. Cerebral glucose metabolism in bipolar disorder: a voxel-based meta-analysis of positron emission tomography studies. Brain Behav. 11, e02117 (2021).","journal-title":"Brain Behav."},{"key":"664_CR11","doi-asserted-by":"publisher","first-page":"384","DOI":"10.3390\/biom10030384","volume":"10","author":"A Bryll","year":"2020","unstructured":"Bryll, A. et al. Oxidative-antioxidant imbalance and impaired glucose metabolism in schizophrenia. Biomolecules 10, 384 (2020).","journal-title":"Biomolecules"},{"key":"664_CR12","doi-asserted-by":"publisher","first-page":"e650","DOI":"10.1212\/WNL.0000000000200771","volume":"99","author":"B Tang","year":"2022","unstructured":"Tang, B. et al. Genetic variation in targets of antidiabetic drugs and Alzheimer disease risk: a Mendelian randomization study. Neurology 99, e650\u2013e659 (2022).","journal-title":"Neurology"},{"key":"664_CR13","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3233\/JAD-2011-101524","volume":"24","author":"C-C Hsu","year":"2011","unstructured":"Hsu, C.-C., Wahlqvist, M. L., Lee, M.-S. & Tsai, H.-N. Incidence of dementia is increased in type 2 diabetes and reduced by the use of sulfonylureas and metformin. J. Alzheimers Dis. 24, 485\u2013493 (2011).","journal-title":"J. Alzheimers Dis."},{"key":"664_CR14","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/nrd3869","volume":"11","author":"A Corbett","year":"2012","unstructured":"Corbett, A. et al. Drug repositioning for Alzheimer\u2019s disease. Nat. Rev. Drug Discov. 11, 833\u2013846 (2012).","journal-title":"Nat. Rev. Drug Discov."},{"key":"664_CR15","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1038\/ng.3314","volume":"47","author":"MR Nelson","year":"2015","unstructured":"Nelson, M. R. et al. The support of human genetic evidence for approved drug indications. Nat. Genet. 47, 856\u2013860 (2015).","journal-title":"Nat. Genet."},{"key":"664_CR16","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.jare.2024.05.002","volume":"70","author":"G Zhao","year":"2024","unstructured":"Zhao, G. et al. Association of intestinal anti-inflammatory drug target genes with psychiatric disorders: a Mendelian randomization study. J. Adv. Res. 70, 545\u2013553 (2024).","journal-title":"J. Adv. Res."},{"key":"664_CR17","doi-asserted-by":"publisher","first-page":"398","DOI":"10.3390\/antiox13040398","volume":"13","author":"Z Lu","year":"2024","unstructured":"Lu, Z. et al. The association of redox regulatory drug target genes with psychiatric disorders: a Mendelian randomization study. Antioxidants 13, 398 (2024).","journal-title":"Antioxidants"},{"key":"664_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105314","volume":"107","author":"Z Chen","year":"2024","unstructured":"Chen, Z. et al. A comprehensive assessment of the association between common drugs and psychiatric disorders using Mendelian randomization and real-world pharmacovigilance database. EBioMedicine 107, 105314 (2024).","journal-title":"EBioMedicine"},{"key":"664_CR19","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1001\/jama.2021.18236","volume":"326","author":"VW Skrivankova","year":"2021","unstructured":"Skrivankova, V. W. et al. Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: the STROBE-MR statement. JAMA 326, 1614\u20131621 (2021).","journal-title":"JAMA"},{"key":"664_CR20","doi-asserted-by":"publisher","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","volume":"46","author":"DS Wishart","year":"2018","unstructured":"Wishart, D. S. et al. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 46, D1074\u2013D1082 (2018).","journal-title":"Nucleic Acids Res."},{"key":"664_CR21","doi-asserted-by":"publisher","first-page":"D930","DOI":"10.1093\/nar\/gky1075","volume":"47","author":"D Mendez","year":"2019","unstructured":"Mendez, D. et al. ChEMBL: towards direct deposition of bioassay data. Nucleic Acids Res. 47, D930\u2013D940 (2019).","journal-title":"Nucleic Acids Res."},{"key":"664_CR22","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1126\/science.aaz1776","volume":"369","author":"GTEx Consortium","year":"2020","unstructured":"GTEx Consortium The GTEx Consortium atlas of genetic regulatory effects across human tissues. Science 369, 1318\u20131330 (2020).","journal-title":"Science"},{"key":"664_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19996-z","volume":"11","author":"M Pietzner","year":"2020","unstructured":"Pietzner, M. et al. Genetic architecture of host proteins involved in SARS-CoV-2 infection. Nat. Commun. 11, 6397 (2020).","journal-title":"Nat. Commun."},{"key":"664_CR24","doi-asserted-by":"publisher","first-page":"S161","DOI":"10.3233\/JAD-179939","volume":"64","author":"DA Bennett","year":"2018","unstructured":"Bennett, D. A. et al. Religious orders study and rush memory and aging project. J. Alzheimers Dis. 64, S161\u2013S189 (2018).","journal-title":"J. Alzheimers Dis."},{"key":"664_CR25","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41588-020-00773-z","volume":"53","author":"AP Wingo","year":"2021","unstructured":"Wingo, A. P. et al. Integrating human brain proteomes with genome-wide association data implicates new proteins in Alzheimer\u2019s disease pathogenesis. Nat. Genet. 53, 143\u2013146 (2021).","journal-title":"Nat. Genet."},{"key":"664_CR26","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1093\/ije\/dyw252","volume":"45","author":"J Bowden","year":"2016","unstructured":"Bowden, J. et al. Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I2 statistic. Int. J. Epidemiol. 45, 1961\u20131974 (2016).","journal-title":"Int. J. Epidemiol."},{"key":"664_CR27","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41588-018-0269-7","volume":"51","author":"D Demontis","year":"2019","unstructured":"Demontis, D. et al. Discovery of the first genome-wide significant risk loci for attention deficit\/hyperactivity disorder. Nat. Genet. 51, 63\u201375 (2019).","journal-title":"Nat. Genet."},{"key":"664_CR28","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/s41588-019-0344-8","volume":"51","author":"J Grove","year":"2019","unstructured":"Grove, J. et al. Identification of common genetic risk variants for autism spectrum disorder. Nat. Genet. 51, 431\u2013444 (2019).","journal-title":"Nat. Genet."},{"key":"664_CR29","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1176\/appi.ajp.2017.16121402","volume":"174","author":"L Duncan","year":"2017","unstructured":"Duncan, L. et al. Significant locus and metabolic genetic correlations revealed in genome-wide association study of anorexia nervosa. Am. J. Psychiatry 174, 850\u2013858 (2017).","journal-title":"Am. J. Psychiatry"},{"key":"664_CR30","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/mp.2017.154","volume":"23","author":"International Obsessive Compulsive Disorder Foundation Genetics Collaborative (IOCDF-GC) and OCD Collaborative Genetics Association Studies (OCGAS","year":"2018","unstructured":"International Obsessive Compulsive Disorder Foundation Genetics Collaborative (IOCDF-GC) and OCD Collaborative Genetics Association Studies (OCGAS) Revealing the complex genetic architecture of obsessive-compulsive disorder using meta-analysis. Mol. Psychiatry 23, 1181\u20131188 (2018).","journal-title":"Mol. Psychiatry"},{"key":"664_CR31","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/s41588-021-00857-4","volume":"53","author":"N Mullins","year":"2021","unstructured":"Mullins, N. et al. Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology. Nat. Genet. 53, 817\u2013829 (2021).","journal-title":"Nat. Genet."},{"key":"664_CR32","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/s41586-022-04434-5","volume":"604","author":"V Trubetskoy","year":"2022","unstructured":"Trubetskoy, V. et al. Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature 604, 502\u2013508 (2022).","journal-title":"Nature"},{"key":"664_CR33","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/s41593-018-0326-7","volume":"22","author":"DM Howard","year":"2019","unstructured":"Howard, D. M. et al. Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions. Nat. Neurosci. 22, 343\u2013352 (2019).","journal-title":"Nat. Neurosci."},{"key":"664_CR34","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1093\/ije\/dyu005","volume":"43","author":"S Burgess","year":"2014","unstructured":"Burgess, S. Sample size and power calculations in Mendelian randomization with a single instrumental variable and a binary outcome. Int. J. Epidemiol. 43, 922\u2013929 (2014).","journal-title":"Int. J. Epidemiol."},{"key":"664_CR35","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1093\/ije\/dyt179","volume":"42","author":"M-JA Brion","year":"2013","unstructured":"Brion, M.-J. A., Shakhbazov, K. & Visscher, P. M. Calculating statistical power in Mendelian randomization studies. Int. J. Epidemiol. 42, 1497\u20131501 (2013).","journal-title":"Int. J. Epidemiol."},{"key":"664_CR36","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/gepi.21758","volume":"37","author":"S Burgess","year":"2013","unstructured":"Burgess, S., Butterworth, A. & Thompson, S. G. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet. Epidemiol. 37, 658\u2013665 (2013).","journal-title":"Genet. Epidemiol."},{"key":"664_CR37","doi-asserted-by":"publisher","first-page":"e34408","DOI":"10.7554\/eLife.34408","volume":"7","author":"G Hemani","year":"2018","unstructured":"Hemani, G. et al. The MR-Base platform supports systematic causal inference across the human phenome. eLife 7, e34408 (2018).","journal-title":"eLife"},{"key":"664_CR38","doi-asserted-by":"publisher","first-page":"e1004383","DOI":"10.1371\/journal.pgen.1004383","volume":"10","author":"C Giambartolomei","year":"2014","unstructured":"Giambartolomei, C. et al. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet. 10, e1004383 (2014).","journal-title":"PLoS Genet."},{"key":"664_CR39","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.ajhg.2022.04.001","volume":"109","author":"V Zuber","year":"2022","unstructured":"Zuber, V. et al. Combining evidence from Mendelian randomization and colocalization: Review and comparison of approaches. Am. J. Hum. Genet. 109, 767\u2013782 (2022).","journal-title":"Am. J. Hum. Genet."},{"key":"664_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104859","volume":"98","author":"N Zhang","year":"2023","unstructured":"Zhang, N., Li, Y., Sundquist, J., Sundquist, K. & Ji, J. Identifying actionable druggable targets for breast cancer: Mendelian randomization and population-based analyses. EBioMedicine 98, 104859 (2023).","journal-title":"EBioMedicine"},{"key":"664_CR41","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1038\/s41588-021-00913-z","volume":"53","author":"U V\u00f5sa","year":"2021","unstructured":"V\u00f5sa, U. et al. Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression. Nat. Genet. 53, 1300\u20131310 (2021).","journal-title":"Nat. Genet."},{"key":"664_CR42","doi-asserted-by":"publisher","first-page":"eadi5199","DOI":"10.1126\/science.adi5199","volume":"384","author":"PS Emani","year":"2024","unstructured":"Emani, P. S. et al. Single-cell genomics and regulatory networks for 388 human brains. Science 384, eadi5199 (2024).","journal-title":"Science"},{"key":"664_CR43","doi-asserted-by":"publisher","first-page":"eaat7615","DOI":"10.1126\/science.aat7615","volume":"362","author":"M Li","year":"2018","unstructured":"Li, M. et al. Integrative functional genomic analysis of human brain development and neuropsychiatric risks. Science 362, eaat7615 (2018).","journal-title":"Science"},{"key":"664_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52121-y","volume":"15","author":"M Liu","year":"2024","unstructured":"Liu, M. et al. Investigating the shared genetic architecture between depression and subcortical volumes. Nat. Commun. 15, 7647 (2024).","journal-title":"Nat. Commun."},{"key":"664_CR45","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1038\/s41588-019-0481-0","volume":"51","author":"K Watanabe","year":"2019","unstructured":"Watanabe, K. et al. A global overview of pleiotropy and genetic architecture in complex traits. Nat. Genet. 51, 1339\u20131348 (2019).","journal-title":"Nat. Genet."},{"key":"664_CR46","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.1093\/bioinformatics\/bti525","volume":"21","author":"S Durinck","year":"2005","unstructured":"Durinck, S. et al. BioMart and Bioconductor: a powerful link between biological databases and microarray data analysis. Bioinformatics 21, 3439\u20133440 (2005).","journal-title":"Bioinformatics"},{"key":"664_CR47","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu, G., Wang, L.-G., Han, Y. & He, Q.-Y. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16, 284\u2013287 (2012).","journal-title":"OMICS"},{"key":"664_CR48","doi-asserted-by":"publisher","first-page":"D1227","DOI":"10.1093\/nar\/gkad1040","volume":"52","author":"M Cannon","year":"2024","unstructured":"Cannon, M. et al. DGIdb 5.0: rebuilding the drug-gene interaction database for precision medicine and drug discovery platforms. Nucleic Acids Res. 52, D1227\u2013D1235 (2024).","journal-title":"Nucleic Acids Res."},{"key":"664_CR49","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1093\/ije\/dyq151","volume":"40","author":"BL Pierce","year":"2011","unstructured":"Pierce, B. L., Ahsan, H. & Vanderweele, T. J. Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants. Int. J. Epidemiol. 40, 740\u2013752 (2011).","journal-title":"Int. J. Epidemiol."},{"key":"664_CR50","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.2174\/1570159X21999221111102343","volume":"21","author":"AS Wee","year":"2023","unstructured":"Wee, A. S., Nhu, T. D., Khaw, K. Y., Tang, K. S. & Yeong, K. Y. Linking diabetes to Alzheimer\u2019s disease: potential roles of glucose metabolism and alpha-glucosidase. Curr. Neuropharmacol. 21, 2036\u20132048 (2023).","journal-title":"Curr. Neuropharmacol."},{"key":"664_CR51","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.neubiorev.2020.02.005","volume":"112","author":"S Kloiber","year":"2020","unstructured":"Kloiber, S. et al. Neurodevelopmental pathways in bipolar disorder. Neurosci. Biobehav. Rev. 112, 213\u2013226 (2020).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"664_CR52","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jad.2013.05.061","volume":"151","author":"K Fletcher","year":"2013","unstructured":"Fletcher, K., Parker, G. & Manicavasagar, V. Behavioral activation system (BAS) differences in bipolar I and II disorder. J. Affect Disord. 151, 121\u2013128 (2013).","journal-title":"J. Affect Disord."},{"key":"664_CR53","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41588-018-0309-3","volume":"51","author":"R Karlsson Linn\u00e9r","year":"2019","unstructured":"Karlsson Linn\u00e9r, R. et al. Genome-wide association analyses of risk tolerance and risky behaviors in over 1 million individuals identify hundreds of loci and shared genetic influences. Nat. Genet. 51, 245\u2013257 (2019).","journal-title":"Nat. Genet."},{"key":"664_CR54","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0306-9877(02)00347-X","volume":"60","author":"PJ Bhat","year":"2003","unstructured":"Bhat, P. J. Galactose-1-phosphate is a regulator of inositol monophosphatase: a fact or a fiction?. Med Hypotheses 60, 123\u2013128 (2003).","journal-title":"Med Hypotheses"},{"key":"664_CR55","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abl6077","volume":"7","author":"S Hirai","year":"2021","unstructured":"Hirai, S. et al. High-sucrose diets contribute to brain angiopathy with impaired glucose uptake and psychosis-related higher brain dysfunctions in mice. Sci. Adv. 7, eabl6077 (2021).","journal-title":"Sci. Adv."},{"key":"664_CR56","doi-asserted-by":"publisher","DOI":"10.5732\/cjc.011.10329","volume":"31","author":"K Sodani","year":"2012","unstructured":"Sodani, K., Patel, A., Kathawala, R. J. & Chen, Z.-S. Multidrug resistance associated proteins in multidrug resistance. Chin. J. Cancer 31, 58 (2012).","journal-title":"Chin. J. Cancer"},{"key":"664_CR57","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1002\/humu.23995","volume":"41","author":"E De Franco","year":"2020","unstructured":"De Franco, E. et al. Update of variants identified in the pancreatic \u03b2-cell KATP channel genes KCNJ11 and ABCC8 in individuals with congenital hyperinsulinism and diabetes. Hum. Mutat. 41, 884\u2013905 (2020).","journal-title":"Hum. Mutat."},{"key":"664_CR58","doi-asserted-by":"publisher","first-page":"11729","DOI":"10.1073\/pnas.1834314100","volume":"100","author":"MV Avshalumov","year":"2003","unstructured":"Avshalumov, M. V. & Rice, M. E. Activation of ATP-sensitive K+ (K(ATP)) channels by H2O2 underlies glutamate-dependent inhibition of striatal dopamine release. Proc. Natl. Acad. Sci. USA 100, 11729\u201311734 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"664_CR59","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.neures.2012.10.002","volume":"74","author":"Y Zhou","year":"2012","unstructured":"Zhou, Y. et al. Enhanced MK-801-induced locomotion in Kir6.2 knockout mice. Neurosci. Res. 74, 195\u2013199 (2012).","journal-title":"Neurosci. Res."},{"key":"664_CR60","doi-asserted-by":"publisher","first-page":"215","DOI":"10.2337\/dc18-1060","volume":"42","author":"P Bowman","year":"2019","unstructured":"Bowman, P. et al. Cognitive, neurological, and behavioral features in adults with KCNJ11 neonatal diabetes. Diabetes Care 42, 215\u2013224 (2019).","journal-title":"Diabetes Care"},{"key":"664_CR61","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1046\/j.1365-2710.2002.00445.x","volume":"27","author":"S Akhondzadeh","year":"2002","unstructured":"Akhondzadeh, S. et al. Diazoxide in the treatment of schizophrenia: novel application of potassium channel openers in the treatment of schizophrenia. J. Clin. Pharm. Ther. 27, 453\u2013459 (2002).","journal-title":"J. Clin. Pharm. Ther."},{"key":"664_CR62","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1476-5381.2012.01871.x","volume":"166","author":"AJ Harmar","year":"2012","unstructured":"Harmar, A. J. et al. Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1. Br. J. Pharmacol. 166, 4\u201317 (2012).","journal-title":"Br. J. Pharmacol."},{"key":"664_CR63","doi-asserted-by":"crossref","unstructured":"Okuda, T. et al. Alterations in inhibitory neuron subtype-selective transcripts in the prefrontal cortex: comparisons across schizophrenia and mood disorders. Psychol. Med. 54, 1\u201310 (2024).","DOI":"10.1017\/S0033291724002344"},{"key":"664_CR64","doi-asserted-by":"publisher","first-page":"11581","DOI":"10.3390\/ijms231911581","volume":"23","author":"W Cai","year":"2022","unstructured":"Cai, W. et al. An integrative analysis of identified schizophrenia-associated brain cell types and gene expression changes. Int. J. Mol. Sci. 23, 11581 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"664_CR65","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1146\/annurev.neuro.25.112701.142754","volume":"25","author":"DA Lewis","year":"2002","unstructured":"Lewis, D. A. & Levitt, P. Schizophrenia as a disorder of neurodevelopment. Annu. Rev. Neurosci. 25, 409\u2013432 (2002).","journal-title":"Annu. Rev. Neurosci."},{"key":"664_CR66","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1093\/oxfordjournals.schbul.a006887","volume":"27","author":"TM Maynard","year":"2001","unstructured":"Maynard, T. M., Sikich, L., Lieberman, J. A. & LaMantia, A. S. Neural development, cell-cell signaling, and the \u2018two-hit\u2019 hypothesis of schizophrenia. Schizophr. Bull. 27, 457\u2013476 (2001).","journal-title":"Schizophr. Bull."},{"key":"664_CR67","doi-asserted-by":"publisher","first-page":"5533","DOI":"10.3390\/ijms25105533","volume":"25","author":"LI Butnariu","year":"2024","unstructured":"Butnariu, L. I. et al. Congenital hyperinsulinism caused by mutations in ABCC8 gene associated with early-onset neonatal hypoglycemia: genetic heterogeneity correlated with phenotypic variability. Int. J. Mol. Sci. 25, 5533 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"664_CR68","doi-asserted-by":"publisher","first-page":"e0249226","DOI":"10.1371\/journal.pone.0249226","volume":"16","author":"K Goto","year":"2021","unstructured":"Goto, K., Mineta, K., Miyazaki, S. & Gojobori, T. Significant variants of type 2 diabetes in the Arabian Region through an Integration of exome databases. PLoS ONE16, e0249226 (2021).","journal-title":"PLoS ONE"},{"key":"664_CR69","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/acps.12439","volume":"132","author":"B Stubbs","year":"2015","unstructured":"Stubbs, B., Vancampfort, D., De Hert, M. & Mitchell, A. J. The prevalence and predictors of type two diabetes mellitus in people with schizophrenia: a systematic review and comparative meta-analysis. Acta Psychiatr. Scand. 132, 144\u2013157 (2015).","journal-title":"Acta Psychiatr. Scand."},{"key":"664_CR70","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/acps.13140","volume":"142","author":"AJ Jackson","year":"2020","unstructured":"Jackson, A. J. & Miller, B. J. Meta-analysis of total and differential white blood cell counts in schizophrenia. Acta Psychiatr. Scand. 142, 18\u201326 (2020).","journal-title":"Acta Psychiatr. Scand."},{"key":"664_CR71","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1093\/schbul\/sbr148","volume":"39","author":"AJ Mitchell","year":"2013","unstructured":"Mitchell, A. J. et al. Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders-a systematic review and meta-analysis. Schizophr. Bull. 39, 306\u2013318 (2013).","journal-title":"Schizophr. Bull."},{"key":"664_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2019.05.010","volume":"163","author":"SM Agarwal","year":"2020","unstructured":"Agarwal, S. M. et al. Brain insulin action in schizophrenia: something borrowed and something new. Neuropharmacology 163, 107633 (2020).","journal-title":"Neuropharmacology"},{"key":"664_CR73","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.ebiom.2018.07.037","volume":"34","author":"Z Li","year":"2018","unstructured":"Li, Z. et al. Glucose and insulin-related traits, type 2 diabetes and risk of schizophrenia: a Mendelian randomization study. EBioMedicine 34, 182\u2013188 (2018).","journal-title":"EBioMedicine"},{"key":"664_CR74","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1017\/S0033291718001812","volume":"49","author":"H-C So","year":"2019","unstructured":"So, H.-C., Chau, K.-L., Ao, F.-K., Mo, C.-H. & Sham, P.-C. Exploring shared genetic bases and causal relationships of schizophrenia and bipolar disorder with 28 cardiovascular and metabolic traits. Psychol. Med. 49, 1286\u20131298 (2019).","journal-title":"Psychol. Med."},{"key":"664_CR75","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2174\/1568026620666191224141617","volume":"20","author":"W Lv","year":"2020","unstructured":"Lv, W., Wang, X., Xu, Q. & Lu, W. Mechanisms and characteristics of sulfonylureas and glinides. Curr. Top. Med. Chem. 20, 37\u201356 (2020).","journal-title":"Curr. Top. Med. Chem."},{"key":"664_CR76","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.1523\/JNEUROSCI.23-07-02744.2003","volume":"23","author":"MV Avshalumov","year":"2003","unstructured":"Avshalumov, M. V., Chen, B. T., Marshall, S. P., Pe\u00f1a, D. M. & Rice, M. E. Glutamate-dependent inhibition of dopamine release in striatum is mediated by a new diffusible messenger, H2O2. J. Neurosci. 23, 2744\u20132750 (2003).","journal-title":"J. Neurosci."},{"key":"664_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2022.116645","volume":"58","author":"C Zhang","year":"2022","unstructured":"Zhang, C. et al. Targeting NLRP3 signaling by a novel-designed sulfonylurea compound for inhibition of microglial inflammation. Bioorg. Med. Chem. 58, 116645 (2022).","journal-title":"Bioorg. Med. Chem."},{"key":"664_CR78","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/s41586-018-0654-5","volume":"563","author":"B Tasic","year":"2018","unstructured":"Tasic, B. et al. Shared and distinct transcriptomic cell types across neocortical areas. Nature 563, 72\u201378 (2018).","journal-title":"Nature"},{"key":"664_CR79","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1083\/jcb.201709072","volume":"217","author":"CL Klaips","year":"2018","unstructured":"Klaips, C. L., Jayaraj, G. G. & Hartl, F. U. Pathways of cellular proteostasis in aging and disease. J. Cell Biol. 217, 51\u201363 (2018).","journal-title":"J. Cell Biol."},{"key":"664_CR80","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nrg3185","volume":"13","author":"C Vogel","year":"2012","unstructured":"Vogel, C. & Marcotte, E. M. Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nat. Rev. Genet. 13, 227\u2013232 (2012).","journal-title":"Nat. Rev. Genet."},{"key":"664_CR81","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/agm2.12294","volume":"7","author":"L Guo","year":"2024","unstructured":"Guo, L. & Xiao, X. Guideline for the management of diabetes mellitus in the elderly in China (2024 Edition). Aging Med. 7, 5\u201351 (2024).","journal-title":"Aging Med."},{"key":"664_CR82","doi-asserted-by":"publisher","first-page":"e0134476","DOI":"10.1371\/journal.pone.0134476","volume":"10","author":"C Lahmann","year":"2015","unstructured":"Lahmann, C., Kramer, H. B. & Ashcroft, F. M. Systemic administration of glibenclamide fails to achieve therapeutic levels in the brain and cerebrospinal fluid of rodents. PLoS ONE 10, e0134476 (2015).","journal-title":"PLoS ONE"}],"container-title":["Schizophrenia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41537-025-00664-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41537-025-00664-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41537-025-00664-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T16:31:36Z","timestamp":1757435496000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41537-025-00664-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,25]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["664"],"URL":"https:\/\/doi.org\/10.1038\/s41537-025-00664-4","relation":{},"ISSN":["2754-6993"],"issn-type":[{"value":"2754-6993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,25]]},"assertion":[{"value":"11 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Only publicly available data were used in this study. Ethical approval and consent to participation were available in the original studies.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical"}}],"article-number":"116"}}